An Inflection Point in Cancer Protein Biomarkers: What was and What's Next

Biomarkers remain the highest value proposition in cancer medicine today—especially protein biomarkers. Despite decades of evolving regulatory frameworks to facilitate the review of emerging technologies, biomarkers have been mostly about promise with very little to show for improvements in human he...

Descripción completa

Detalles Bibliográficos
Autores principales: Barker, Anna D., Alba, Mario M., Mallick, Parag, Agus, David B., Lee, Jerry S.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388583/
https://www.ncbi.nlm.nih.gov/pubmed/37196763
http://dx.doi.org/10.1016/j.mcpro.2023.100569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388583/
https://www.ncbi.nlm.nih.gov/pubmed/37196763
http://dx.doi.org/10.1016/j.mcpro.2023.100569

Ejemplares similares